A Descriptive Analysis of Factors Leading to a 1-Year Remission in Bipolar Disorder

Journal of Psychiatric Practice
Daniel RapportThomas Fine

Abstract

Bipolar spectrum disorders are associated with symptomatic and functional disability in many patients. Other studies have examined predictors of outcome with variable results. The goal of this retrospective study was to identify medications associated with a minimum of 12 consecutive months of symptomatic, functional, and syndromal remission. The charts of 121 patients with confirmed bipolar disorder were reviewed. Data on medical regimen and demographic and adherence factors were gathered using standardized data collection sheets approved by the University of Toledo Institutional Review Board. The criterion for improvement was set at 12 consecutive months of Clinical Global Impressions Improvement ratings of ≤2, which is a far higher standard of syndromal and functional remissions than the usual 8 consecutive weeks used by the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. In this sample of 121 patients, 43.8% achieved a minimum of 12 consecutive months of remission, whereas 56.2% did not. When bipolar disorder was divided into its subtypes, 45.5% of our cohort were diagnosed with bipolar I disorder, 27.3% were diagnosed with bipolar II disorder, and 27.3% were diagnosed with bipolar disorde...Continue Reading

References

Mar 1, 1995·The American Journal of Psychiatry·J F GoldbergL S Grossman
Jun 5, 2002·Archives of General Psychiatry·Lewis L JuddMartin B Keller
Feb 3, 2005·Social Psychiatry and Psychiatric Epidemiology·Evelyn J BrometQing Ye
Jun 9, 2005·Archives of General Psychiatry·Ronald C KesslerEllen E Walters
Mar 30, 2007·The New England Journal of Medicine·Gary S SachsMichael E Thase
May 9, 2007·Archives of General Psychiatry·Kathleen R MerikangasRonald C Kessler
Jan 29, 2008·Current Psychiatry Reports·Michael E Thase
Jan 30, 2009·Psychiatric Services : a Journal of the American Psychiatric Association·Babak Roshanaei-Moghaddam, Wayne Katon

❮ Previous
Next ❯

Citations

May 28, 2020·International Clinical Psychopharmacology·Yoo Hyun UmJong-Hyun Jeong
Mar 4, 2021·Journal of Psychiatric Practice·Daniel RapportDenis Lynch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Progress in Neuro-psychopharmacology & Biological Psychiatry
Haluk A SavasSalih Selek
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
Jooyoung OhKeun-Ah Cheon
© 2021 Meta ULC. All rights reserved